Skip to Content
Søg Menu
Onkologi
Velkommen til onkologi

Få de seneste artikler og MEDtalks fra onkologi

Nyt fra onkologi

Ny non-hormonel behandling reducerer hedeture og nattesved hos kvinder i adjuverende endokrin behandling for hormonreceptor -positiv brystkræft

/ Bayer
Paolo Ascierto

Nine-Year Outcomes with Nivolumab in Melanoma

/ Paolo Ascierto
Malignt melanom Play the Video
Martin Eklund

WISDOM: Risk-Based Breast Cancer Screening

/ Martin Eklund
Brystcancer Play the Video

Ny non-hormonel behandling reducerer hedeture og nattesved hos kvinder i adjuverende endokrin behandling for hormonreceptor -positiv brystkræft

/ Bayer
Louise Elkjær Fløe

CASEMED: A Supportive Cancer Care Model for Patients with Severe Mental Disorders

/ Louise Elkjær Fløe
Cancer Play the Video
Jason Jincong Freeman

Chemotherapy Use After the RxPONDER Trial

/ Jason Jincong Freeman
Brystcancer Play the Video
Hent flere

ASCO 2026

Van Gorp Toon

ASCO 2026: TUB-040 in Platinum-Resistant Ovarian Cancer

/ Van Gorp Toon
ASCO26Ovariecancer Play the Video
Jana De Boniface

ASCO 2026: SENOMAC Supports Omission of Completion Axillary Dissection

/ Jana de Boniface
ASCO26Brystcancer Play the Video
Pedro Barata

ASCO 2026: Phase III Study Evaluates Novel Radiopharmaceutical in mCRPC

/ Pedro Barata
ASCO26Prostatacancer Play the Video
Gini Fleming

ASCO 2026: Telisotuzumab Adizutecan Shows Promising Activity in Platinum-Resistant Ovarian Cancer

/ Gini Fleming
ASCO26Ovariecancer Play the Video
Mattia D' Agostino

ASCO 2026: Sustained MRD and Outcomes in Multiple Myeloma

/ Mattia D' Agostino
ASCO26Myelomatose Play the Video
Martin Birkmose Rasmussen

ASCO 2026: Biomarkers May Improve Treatment Selection and Respons in BTC

/ Martin Birkmose Rasmussen
ASCO26 Play the Video
Hent flere

Kommende events

WCLC 2026 Highlights Nordic Webinar

International Breast Cancer Round Table: Bringing Global Insights to Nordic Practice

Nordic Evening ESMO 2026

Zacharoula Sidiropoulou

Cost-Effectiveness of Breast Cancer Screening in Europe

/ Zacharoula Sidiropoulou
Brystcancer Play the Video

Onkologi • Nr. 16 • 2026

  • Flere vil opnå klinisk respons ved fremtidens immunterapi
  • Ny 1. linje behandling af ALK+ NSCLC giver markante kliniske fordele
  • Kombinationsbehandling af blærecancer forbedrer behandlingen radikalt
Get access

ELCC 2026

  • Meet the Experts
  • 2026
Get access

Lungecancer side

Besøg vores lungecancer side
og hold dig opdateret med den seneste forskning

Besøg side

Følg med i nyt fra kongresser

Back to top